PhageLab Chile SpA

Founded in 2010 and headquartered in Santiago, Chile, PhageLab Chile SpA focuses on biotechnology solutions using bacteriophages.PhageLab specializes in developing innovative solutions utilizing bacteriophages, which are natural viruses that specifically target and eliminate bacterial pathogens. The company’s core offerings include customized bacteriophage cocktails tailored to combat specific bacterial infections affecting livestock and poultry, ultimately enhancing animal health and farm productivity. Their products are underpinned by a robust machine-learning approach that allows for the selection and optimization of bacteriophage combinations to effectively inhibit harmful bacteria. PhageLab’s clientele primarily consists of livestock and poultry producers across various geographical markets, including Latin America, with notable customer presence in Chile, Brazil, and the broader Southern Cone region.PhageLab's revenue model is built around partnerships and B2B transactions with livestock and poultry producers. Revenue is generated through the sale of bacteriophage cocktails and associated consulting services that facilitate the application of these products in the field. Clients typically engage with PhageLab through structured agreements that may involve initial diagnosis followed by the provision of tailored phage solutions, ensuring ongoing support and optimization of animal health management strategies. The company’s flagship products, such as INSPEKTOR and FÓRMIDA, are integral to these transactions, where clients receive comprehensive solutions that include both the bacteriophage treatments and the necessary training for application.

1. Seed

   Jun 1, 2018

   Amount

   $4M

   Investors

   Locked